Laboratory of Systems Cancer Biology, Rockefeller University, Box 16, 1230 York Avenue, New York, NY 10065, USA; Department of Biomedicine, University of Bergen, Jonas Liesvej 91, 5020 Bergen, Norway.
Laboratory of Systems Cancer Biology, Rockefeller University, Box 16, 1230 York Avenue, New York, NY 10065, USA.
Cancer Cell. 2016 Mar 14;29(3):339-353. doi: 10.1016/j.ccell.2016.02.013.
Enhanced secretion of tumorigenic effector proteins is a feature of malignant cells. The molecular mechanisms underlying this feature are poorly defined. We identify PITPNC1 as a gene amplified in a large fraction of human breast cancer and overexpressed in metastatic breast, melanoma, and colon cancers. Biochemical, molecular, and cell-biological studies reveal that PITPNC1 promotes malignant secretion by binding Golgi-resident PI4P and localizing RAB1B to the Golgi. RAB1B localization to the Golgi allows for the recruitment of GOLPH3, which facilitates Golgi extension and enhanced vesicular release. PITPNC1-mediated vesicular release drives metastasis by increasing the secretion of pro-invasive and pro-angiogenic mediators HTRA1, MMP1, FAM3C, PDGFA, and ADAM10. We establish PITPNC1 as a PI4P-binding protein that enhances vesicular secretion capacity in malignancy.
肿瘤效应蛋白的分泌增强是恶性细胞的一个特征。这种特征的分子机制还不清楚。我们鉴定出 PITPNC1 是在很大一部分人类乳腺癌中扩增的基因,并在转移性乳腺癌、黑色素瘤和结肠癌中过度表达。生化、分子和细胞生物学研究表明,PITPNC1 通过结合高尔基体驻留的 PI4P 并将 RAB1B 定位到高尔基体,促进恶性分泌。RAB1B 向高尔基体的定位允许 GOLPH3 的募集,从而促进高尔基体延伸和增强囊泡释放。PITPNC1 介导的囊泡释放通过增加促侵袭和促血管生成介质 HTRA1、MMP1、FAM3C、PDGFA 和 ADAM10 的分泌来驱动转移。我们将 PITPNC1 确定为一种 PI4P 结合蛋白,可增强恶性肿瘤中的囊泡分泌能力。